$266 Million is the total value of DAFNA Capital Management LLC's 87 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 32.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $39,673,000 | +48.7% | 13,680,554 | 0.0% | 14.91% | +29.6% | |
| SAGE | SAGE THERAPEUTICS INC | $22,668,000 | +15.1% | 123,806 | 0.0% | 8.52% | +0.3% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $11,623,000 | +21.3% | 123,218 | +2.9% | 4.37% | +5.7% |
| ATRC | ATRICURE INC | $9,511,000 | +11.4% | 318,729 | 0.0% | 3.58% | -3.0% | |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $7,486,000 | -4.0% | 636,013 | +11.4% | 2.81% | -16.3% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $6,838,000 | +30.9% | 59,380 | +33.8% | 2.57% | +14.0% |
| GLPG | Buy | GALAPAGOS NVspon adr | $6,770,000 | +15.9% | 52,509 | +5.8% | 2.54% | +1.0% |
| ZGNX | Buy | ZOGENIX INC | $6,726,000 | -5.8% | 140,764 | +8.5% | 2.53% | -17.9% |
| IBB | ISHARES TR NASDAQ BIOTECHetf | $6,699,000 | -2.4% | 61,400 | 0.0% | 2.52% | -15.0% | |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $6,071,000 | -15.8% | 205,440 | +35.4% | 2.28% | -26.6% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $5,676,000 | -23.3% | 217,554 | +14.2% | 2.13% | -33.2% |
| ARNA | ARENA PHARMACEUTICALS INC | $5,508,000 | +30.8% | 93,942 | 0.0% | 2.07% | +13.9% | |
| ARQL | Buy | ARQULE INC | $5,480,000 | +206.7% | 497,762 | +33.4% | 2.06% | +167.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $5,455,000 | +12.6% | 64,608 | +17.5% | 2.05% | -1.9% |
| DXCM | Buy | DEXCOM INC | $5,445,000 | +41.4% | 36,338 | +12.4% | 2.05% | +23.2% |
| CYTK | Buy | CYTOKINETICS INC | $5,368,000 | +65.8% | 477,196 | +19.2% | 2.02% | +44.5% |
| ARGX | Sell | ARGENX SEsponsored adr | $4,495,000 | +1.0% | 31,750 | -10.9% | 1.69% | -12.0% |
| CARA | Buy | CARA THERAPEUTICS INC | $4,408,000 | +56.4% | 205,011 | +42.8% | 1.66% | +36.3% |
| BHVN | Buy | BIOHAVEN PHARMACEUTICALS HOLD | $4,160,000 | +1.0% | 95,000 | +18.8% | 1.56% | -12.0% |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $4,020,000 | -31.4% | 830,538 | +16.1% | 1.51% | -40.2% |
| LMNX | Buy | LUMINEX CORP | $4,006,000 | +25.8% | 194,091 | +40.2% | 1.51% | +9.6% |
| ELOX | New | ELOXX PHARMACEUTICALS INC | $3,739,000 | – | 375,000 | +100.0% | 1.40% | – |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,624,000 | +8.6% | 4,000,000 | 0.0% | 1.36% | -5.4% | ||
| MNLO | MENLO THERAPEUTICS INC | $3,594,000 | -23.7% | 600,030 | 0.0% | 1.35% | -33.5% | |
| XENE | XENON PHARMACEUTICALS INC | $3,260,000 | -3.0% | 330,667 | 0.0% | 1.22% | -15.5% | |
| BLUE | Sell | BLUEBIRD BIO INC | $3,244,000 | -23.6% | 25,500 | -5.6% | 1.22% | -33.5% |
| GNCA | New | GENOCEA BIOSCIENCES INC | $2,879,000 | – | 734,422 | +100.0% | 1.08% | – |
| CRTX | New | CORTEXYME INC | $2,780,000 | – | 65,400 | +100.0% | 1.04% | – |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $2,624,000 | +280.8% | 200,013 | +175.9% | 0.99% | +232.0% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $2,506,000 | -32.3% | 349,996 | +25.5% | 0.94% | -41.0% |
| PRQR | PROQR THERAPEUTICS N V | $2,380,000 | -34.4% | 261,521 | 0.0% | 0.90% | -42.8% | |
| TBIO | New | TRANSLATE BIO INC | $2,252,000 | – | 178,306 | +100.0% | 0.85% | – |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $2,198,000 | +1.2% | 51,200 | -8.9% | 0.83% | -11.8% |
| BEAT | Buy | BIOTELEMETRY INC | $2,181,000 | +0.1% | 45,300 | +30.2% | 0.82% | -12.8% |
| EPZM | New | EPIZYME INC | $2,178,000 | – | 173,536 | +100.0% | 0.82% | – |
| CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $2,060,000 | -2.8% | 297,300 | -2.5% | 0.77% | -15.4% |
| ARAY | New | ACCURAY INC | $2,029,000 | – | 524,300 | +100.0% | 0.76% | – |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $1,923,000 | -36.5% | 808,000 | 0.0% | 0.72% | -44.7% | |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $1,863,000 | +3.1% | 118,314 | -4.1% | 0.70% | -10.3% |
| ARDX | Buy | ARDELYX INC | $1,834,000 | -3.2% | 681,759 | +0.7% | 0.69% | -15.8% |
| KDMN | Buy | KADMON HOLDINGS INC | $1,826,000 | -8.7% | 886,177 | +17.0% | 0.69% | -20.4% |
| Buy | INTEC PHARMA LTD JERUSALEM | $1,805,000 | -35.5% | 415,989 | +9.0% | 0.68% | -43.7% | |
| VKTX | Buy | VIKING THERAPEUTICS INC | $1,736,000 | -2.5% | 209,200 | +16.7% | 0.65% | -15.0% |
| NVRO | Sell | NEVRO CORP | $1,699,000 | -12.9% | 26,210 | -16.0% | 0.64% | -24.1% |
| SCYX | SCYNEXIS INC | $1,668,000 | -13.2% | 1,272,927 | 0.0% | 0.63% | -24.4% | |
| ACHN | Sell | ACHILLION PHARMACEUTICALS | $1,621,000 | -11.9% | 604,884 | -2.6% | 0.61% | -23.2% |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $1,610,000 | – | 100,000 | +100.0% | 0.60% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $1,557,000 | -61.6% | 410,888 | -17.6% | 0.58% | -66.6% |
| INGN | Buy | INOGEN INC | $1,535,000 | +62.6% | 23,000 | +132.3% | 0.58% | +41.8% |
| NXTC | New | NEXTCURE INC | $1,440,000 | – | 96,100 | +100.0% | 0.54% | – |
| GMDA | New | GAMIDA CELL LTD | $1,397,000 | – | 275,000 | +100.0% | 0.52% | – |
| AGTC | APPLIED GENETIC TECHNOL CORP | $1,361,000 | -9.6% | 359,190 | 0.0% | 0.51% | -21.1% | |
| JNJ | JOHNSON AND JOHNSON | $1,309,000 | -0.4% | 9,400 | 0.0% | 0.49% | -13.2% | |
| FATE | New | FATE THERAPEUTICS INC | $1,219,000 | – | 60,031 | +100.0% | 0.46% | – |
| MORF | New | MORPHIC HOLDING INC | $1,189,000 | – | 60,000 | +100.0% | 0.45% | – |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $1,115,000 | -47.4% | 275,236 | -31.8% | 0.42% | -54.2% |
| NTUS | NATUS MEDICAL INC | $1,102,000 | +1.2% | 42,900 | 0.0% | 0.41% | -11.9% | |
| DERM | Buy | DERMIRA INC | $994,000 | +2.6% | 104,000 | +45.5% | 0.37% | -10.5% |
| PRVL | New | PREVAIL THERAPEUTICS INC | $990,000 | – | 75,000 | +100.0% | 0.37% | – |
| KURA | Buy | KURA ONCOLOGY INC | $930,000 | +53.5% | 47,242 | +29.2% | 0.35% | +34.1% |
| MGNX | MACROGENICS INC | $849,000 | -5.6% | 50,000 | 0.0% | 0.32% | -17.8% | |
| SPRO | SPERO THERAPEUTICS INC | $806,000 | -10.1% | 70,000 | 0.0% | 0.30% | -21.7% | |
| INSM | New | INSMED INC | $768,000 | – | 30,000 | +100.0% | 0.29% | – |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $692,000 | -16.3% | 6,600 | 0.0% | 0.26% | -27.2% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $682,000 | -31.5% | 50,573 | 0.0% | 0.26% | -40.5% | |
| OBSV | Buy | OBSEVA SA | $564,000 | +1.6% | 49,848 | +14.8% | 0.21% | -11.3% |
| GRTS | New | GRITSTONE ONCOLOGY INC | $557,000 | – | 50,000 | +100.0% | 0.21% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $548,000 | -17.6% | 24,725 | +6.5% | 0.21% | -28.2% |
| URGN | UROGEN PHARMA LTD | $539,000 | -2.7% | 15,000 | 0.0% | 0.20% | -15.1% | |
| RDUS | Sell | RADIUS HEALTH INC | $536,000 | -36.0% | 22,000 | -47.6% | 0.20% | -44.3% |
| MASI | MASIMO CORPORATION | $446,000 | +7.5% | 3,000 | 0.0% | 0.17% | -6.1% | |
| ALEC | Sell | ALECTOR INC | $440,000 | -52.1% | 23,166 | -52.8% | 0.16% | -58.3% |
| DEXCOM INCnote 0.750% 5/1 | $399,000 | +18.8% | 250,000 | 0.0% | 0.15% | +3.4% | ||
| STRO | SUTRO BIOPHARMA INC | $358,000 | -0.3% | 31,494 | 0.0% | 0.14% | -12.9% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $359,000 | +1.4% | 137,600 | 0.0% | 0.14% | -11.8% | |
| CDTX | CIDARA THERAPEUTICS INC | $357,000 | -36.7% | 212,766 | 0.0% | 0.13% | -44.9% | |
| ZFGN | Sell | ZAFGEN INC | $340,000 | -62.6% | 285,500 | -14.0% | 0.13% | -67.4% |
| SLGL | SOL GEL TECHNOLOGIES LTD | $319,000 | +34.6% | 35,000 | 0.0% | 0.12% | +17.6% | |
| ALDX | ALDEYRA THERAPEUTICS INC | $300,000 | -33.6% | 50,000 | 0.0% | 0.11% | -42.1% | |
| ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $232,000 | -3.3% | 250,000 | 0.0% | 0.09% | -16.3% | ||
| KRTX | New | KARUNA THERAPEUTICS INC | $200,000 | – | 10,000 | +100.0% | 0.08% | – |
| BTX | BIOTIME INC | $105,000 | -15.3% | 95,000 | 0.0% | 0.04% | -26.4% | |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $92,000 | – | 6,265 | +100.0% | 0.04% | – |
| ALRN | AILERON THERAPEUTICS INC | $72,000 | -62.9% | 99,502 | 0.0% | 0.03% | -67.9% | |
| ORMP | Sell | ORAMED PHARMACEUTICALS INC | $57,000 | -40.0% | 16,000 | -38.5% | 0.02% | -48.8% |
| BLCM | BELLICUM PHARMACEUTICALS INC | $51,000 | -49.5% | 30,000 | 0.0% | 0.02% | -56.8% | |
| ARCT | New | ARCTURUS THERAPEUTICS HLDG I | $23,000 | – | 2,400 | +100.0% | 0.01% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -5,052 | -100.0% | -0.04% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -36,084 | -100.0% | -0.12% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS LTD | $0 | – | -47,255 | -100.0% | -0.14% | – |
| SVRA | Exit | SAVARA INC | $0 | – | -110,275 | -100.0% | -0.35% | – |
| ABUS | Exit | ARBUTUS BIOPHARMA CORP | $0 | – | -246,900 | -100.0% | -0.38% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -1,989,653 | -100.0% | -0.51% | – |
| ADXS | Exit | ADVAXIS INC | $0 | – | -202,222 | -100.0% | -0.52% | – |
| VBIV | Exit | VBI VACCINES INC | $0 | – | -850,000 | -100.0% | -0.69% | – |
| Exit | INSULET CORPnote 1.375% | $0 | – | -1,500,000 | -100.0% | -0.78% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.